Slocum, Gordon & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ATO
Slocum, Gordon & Co's MRK Position: Q2 2026 in Review
Slocum, Gordon & Co reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $148K and leaving 93,181 shares worth $12M. The position accounts for 7.95% of the portfolio, ranked #1.
Slocum, Gordon & Co first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $14.5M in Q4 2022. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Slocum, Gordon & Co held 93,181 shares of Merck worth $12M as of Q2 2026.
- Slocum, Gordon & Co sold 1,267 Merck shares in Q2 2026, an estimated $148K.
- Merck made up 7.95% of Slocum, Gordon & Co's portfolio in Q2 2026, its #1 holding.
- Slocum, Gordon & Co first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
- Slocum, Gordon & Co's Merck position peaked at $14.5M in Q4 2022.
- 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Slocum, Gordon & Co's 13F filing for Q2 2026, filed 23 Jul 2026.